NIH Academic Career Award K07

Program Description:
The purpose of the National Institutes of Health (NIH) Academic Career Award (K07) is to provide support to increase the pool of individuals with academic and research expertise to become academic researchers and to enhance the educational or research capacity at the grantee sponsoring grantee institution.

The Academic Career Award supports K07 development awards for more junior level candidates and K07 leadership awards for more senior individuals with acknowledged scientific expertise and leadership skills. Prospective candidates are encouraged to contact the relevant NIH staff for institute/center(IC)-specific programmatic and budgetary information. This funding opportunity announcement (FOA) will utilize the K07 award mechanism.

Because the nature and scope of the proposed career award program will vary from application to application and the amounts provided by the participating ICs are not uniform, it is anticipated that the size and duration of each award will also vary. Candidates may request up to 5 years of support (at least 3 years are required for the K07 Development award, and at least 2 years are required for the K07 Leadership award).

http://grants.nih.gov/grants/guide/pa-files/PA-10-058.html?CFID=9054716&CFTOKEN=20379825

New RCR Presentations Scheduled

New Responsible Conduct of Research presentations by the Office of the Provost have been scheduled.

• Tuesday, March 23
• Tuesday, May 25

All Sessions:
Time:  3-5 pm
Location:  DCAL (in Baker Library)

DOD Breast Cancer Research Program

The Fiscal Year 2010 (FY10) Defense Appropriations Act provides $150 million to the Department of Defense (DOD) Breast Cancer Research Program (BCRP) to promote innovative research focused on eradicating breast cancer. This program is administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) through the Office of the Congressionally Directed Medical Research Programs (CDMRP). A summary of BCRP funding opportunities is provided below. Detailed descriptions of each of the funding mechanisms, evaluation criteria, and submission requirements can be found in the FY10 BCRP Program Announcements. Each Program Announcement is available electronically for downloading from the Grants.gov website (), the CDMRP website () and the CDMRP eReceipt Website (https://cdmrp.org/).

Submission Deadlines:

Era of Hope Scholar Award
Pre-Application: March 24, 2010
Application: April 7, 2010

Innovator Award
Pre-Application: March 24, 2010
Application: April 7, 2010

Postdoctoral Fellowship Award
Pre-Application: March 24, 2010
Application: April 7, 2010

Predoctoral Traineeship Award
Pre-Application: March 24, 2010
Application: April 7, 2010

Idea Award
Pre-Application: April 21, 2010
Application: May 5, 2010

Idea Award- Collaborative Option
Pre-Application: April 21, 2010
Application: May 5, 2010

Transformative Vision Award
Pre-Proposal: March 18, 2010
Invited Application: June 23, 2010

Inter-Institutional Training Award
Pre-Proposal: March 18, 2010
Invited Application: June 23, 2010

Multi-Team Award
Pre-Proposal: March 18, 2010
Invited Application: June 23, 2010



----------------------------------------------------------------------

NIH ARRA Comparative Effectiveness Research Clinical Trials

Title: ARRAOS: Recovery Act Limited Competition: Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research: Clinical Trials (RC4)

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-001.html

Purpose. This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH and AHRQ under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites applications proposing clinical trials using the principles of behavioral economics to enhance the uptake of the results of comparative effectiveness research (CER) among health care providers in their practice. For this FOA, applicants must propose controlled trials that randomize units (whether individuals or clusters such as practices, hospitals, or larger units) to conditions, resulting in a randomized clinical trial (RCT) or cluster randomized trial (CRT). Research to foster the uptake of CER is seen to be necessary given the surprisingly modest behavioral response of health care providers and health care systems to information concerning treatments or procedures judged to be superior in CER trials. An additional possible benefit is that some behavioral economic interventions to promote the uptake of CER (e.g., those that rely on manipulating a provider’s default options) could be more cost effective than conventional approaches including some pay for performance schemes (P4P). For the purposes of this FOA, the definition of comparative effectiveness research will adhere to that adopted by the Federal Coordinating Council given at http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf. Behavioral economics refers to the interdisciplinary efforts involving cognitive and social psychologists, decision scientists, and other social scientists together with economists to model economic decision-making and consequent actions. The approach is inclusive, since at its heart it tries to take into account what is known about how people actually make decisions rather than relying on the assumption that economic agents are fundamentally rational in the sense of expected utility theory (see, e.g., Kahneman and Tversky’s (1979) work on Prospect Theory and Kahneman’s (2003) Nobel lecture). It is hoped that this line of research will lead to significantly greater consideration of CER by health care providers and therefore enhance the quality of the nation’s health.

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-001.html

May 28, 2010 Research Grants Lupus

NEW RESEARCH GRANTS FOR NOVEL APPROACHES TO LUPUS

Grant Application Deadline: May 28, 2010

The Lupus Research Institute (LRI) – founded to support highly promising, idea-driven, novel approaches to discover the cause, improve treatment, and cure lupus – invites applications for financial support starting December 2010 for Novel Research Projectsrelevant to Systemic Lupus Erythematosus.

Research applications will be judged principally on novelty of the hypotheses, scientific quality, strength of approach, relevance to lupus, and likelihood of success. Creativity will be valued. Rationale for the hypotheses proposed rather than amount of preliminary data will be emphasized.

http://www.lupusresearchinstitute.org/research/grant_application

Yahoo Key Scientific Challenges Program

Yahoo! Labs is working hard to develop world-class science that will unveil the next generation of the Internet, and we want you to join us.

This is your chance to get an inside look at the big challenges Yahoo! research scientists are working on while driving your research forward. Learn more about the real-world problems facing our industry, then focus on and solve these fundamental challenges alongside the top minds in the field.

As a part of the Yahoo! Key Scientific Challenges Program, you’ll receive $5,000 seed funding, exclusive access to Yahoo! research scientists and select datasets, and an invite to the Key Scientific Challenges Graduate Student Summit.

We invite PhD students working in each of our core research areas to review the challenges listed below and submit an application between January 25th and March 5th, 2010 to be considered for the Key Scientific Challenges Program.

http://labs.yahoo.com/ksc?CFID=9033722&CFTOKEN=56504756

Damon Runyon Rachleff Innovation Award

See Complete Announcement at
http://www.damonrunyon.org/for_scientists/more/innovation_award_overview#eligibility


Program Description

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high risk/high reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.
The Innovation award is specifically designed to provide funding for extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.
Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators. All awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Innovation Award Committee.

Funding•

The award will be for a period of three years. Each award will provide a total of $450,000 in direct costs. The Award cannot be used for indirect costs or institutional overhead.•Awards will be paid in increments of $150,000 per year for three years. However, the Innovation Award Committee will consider an accelerated payment schedule if an award recipient can demonstrate compelling need.
•The Innovation Award funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s salary, salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research.
•The submitted budgets should be realistic estimates of the funds required for the proposed research and be itemized by category according to the instructions on the budget form.
•No part of this award may be used for indirect costs or institutional overhead.

NIH Reminder on Forms

http://funding.niaid.nih.gov/ncn/newsletters/2010/0217.htm#n02b

A reminder from NIH

Do Not Use Adobe-Forms-A
Adobe-Forms-A will go through Grants.gov, but NIH will reject your application.


Even though you may see Adobe-Forms-A application packages in Grants.gov, NIH no longer accepts them.

If you do fill them out by mistake, they will go through Grants.gov, but NIH will reject your application, and it will not be considered for funding.

Just be sure you choose Adobe-Forms-B from now on

NIH Shared Instrumentation Deadline

The National Center for Research Resources (NCRR) Shared Instrument Grant program encourages applications from groups of National Institutes of Health (NIH)-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instrumentation or an integrated system that costs at least $100,000. The maximum award is $600,000. Types of instruments supported include (1) confocal and electron microscopes, (2) biomedical imagers, (3) mass spectrometers, (4) DNA sequencers, (5) biosensors, (6) cell sorters, (7) X-ray diffraction systems, and (8) nuclear magnetic resonance spectrometers, among others.

This funding opportunity will use the NIH S10 mechanism. NCRR intends to commit approximately $43 million in fiscal year 2011, to fund approximately 125 new awards. Since the cost of the various instruments will vary, it is anticipated that the size of awards will also vary.
Program Restrictions:
Under the general research support authority of Section 301(a) (3) of the Public Health Service Act, Shared Instrumentation Grant awards are made to public and non-profit domestic institutions only. These institutions include health professional schools, other academic institutions, hospitals, health departments, and research organizations. Note that federal institutions, foreign institutions, and for-profit institutions are not eligible to apply. A Federal institution is defined by the NIH as a Cabinet-level department or independent agency of the executive branch of the Federal Government or any component organization of such a department or agency.

Eligible principal investigators include any technically qualified research scientists. To be eligible to apply, three or more NIH funded investigators (Principal Investigators of active P01, R01, U01, R35, R37, DP1 or DP2 research grants) who will be users of the requested instruments must be identified.

There is no limit on the number of applications an institution may submit provided the applications are for different types of equipment.

Applicants may submit a resubmission application, but such applications must include an Introduction addressing the previous peer review critique (Summary Statement). See new NIH policy on resubmission (amended) applications (NOT-OD-09-003, NOT-OD-09-016).

Renewal (formerly "competing continuation" or "Type 2") applications are not permitted.

http://grants.nih.gov/grants/guide/pa-files/PAR-10-082.html?CFID=8938339&CFTOKEN=83417786

Sontag Foundation Distinguished Scientist Awards

In October 2010, The Sontag Foundation will present up to three Distinguished Scientist Awards to the most outstanding early career scientists with inspiring, potential-laden brain cancer research proposals. Each Award consists of a four-year funding component totaling a maximum of $600,000Up to three grants will be awarded. Each award consists of a four-year funding component at up to $150,000 per year, totaling a maximum of $600,000. Application deadline is March 24, 2010
http://www.sontagfoundation.org/grant_opps/grant_opps_dsa.htm

OSP Updates Newsletter for February 2010

OSP has released the February 2010 Issue of OSP News Updates.

Included in this issue:

• NIH Updates
• NSF Updates
• RCR Training
• Human Frontiers Science Program
• Preaward Corner
• OSP Blog
• Funding Opps